Specialties: Pharmaceuticals Distribution and Market Launches, Pharma Sales, financial consulting andcorporate venture capital. International Corporate Communications and Mass media management.Finance and Accounting: Financial Management with broad experience in all aspects of accounting, tax ...

• Executive Director
• Company NameTAJ PHARMA
• Dates EmployedJan 2011 – Present
• Employment Duration8 yrs 2 mos
• International Business Operations, Communication and International Conference, ContractManufacturing and Sales, Project Financial Forecasts and Planning, Corporate Capital Venturing,Bonds and Debenture handling.
• 
  
• Management Strategic Consulting including business plan & international sales strategydevelopment.
• 
  
• Corporate Communication, Global Media and Press Releases, Spokesperson European C... See more

Founder & CEO

Company NameTAJ INFOTECH INC.

Dates EmployedJan 2014 – Present

Employment Duration5 yrs 2 mos

LocationGlobal

Knowledge is Key to today's Information Age, this is a New Type of I.T. Firm, provides a full range ofinnovative Web presence products & services to Web Hosts, Web Designers, TechnologyConsultants and I.T Resellers worldwide. Most innovative cloud technology by our global datacenters based in Austin, UK, India and Hong Kong. more: http://shop.tajinfotech.com/

Creative Director

Company NameTAJ AGRO

Dates EmployedJun 2014 – Present

Employment Duration4 yrs 9 mos

LocationMumbai Area, India

Introducing New Products, Business Re-modeling, Business Restructuring, Recovery and turnaround.

Director Sales

Company NameTaj API

Dates EmployedJul 2013 – Jan 2016

Employment Duration2 yrs 7 mos

LocationMumbai Area, India

Taj Active Pharmaceutical Ingredients (or Taj API) is an international pharmaceutical api companybased in India. Taj Api introduced Oseltamivir Phosphate ( INN) which is drug used for H5N1 avianinfluenza. The company was first to manufacture the raw martial for such a cause in India.

Expert Committee (EMA)

Company NameWorld Health Organization

Dates EmployedApr 2014 – Nov 2014

Employment Duration8 mos

LocationGeneva, Switzerland

Nominated Member of the Expert Committee on Selection and Use of Essential Medicines.Applications, inclusion, change or deletion of a medicine in the Model List of Essential Medicines.Nominated Inclusion of oncology medicines in the WHO Essential Medicines List.

Show 2 more experiences

Education

• University of Durham
• Field Of StudyAccounting and Finance
• GradeFirst-Class Honours (Academic Achievement Award For Highest Marks Achiever)
• Activities and Societies: Business School Representative - Durham Board of Studies, Course Representative, Durham University Investment & Finance Group (DUIFG), Campus Rep - International Students Association Committee.

Accomplishments

Shantanu Kumar has 4 publications4

Publications

• In-depth review on ‘innovation and regulatory challenges of the drug delivering medical devices’
• Indian drug makers fit into Russia's pharma strategy
• Economic slowdown of the third largest economy of the world, can it realise the double digit growth rate?
• TF1 Survey – European Markets dependence on China and India for medicines supply

Shantanu Kumar has 3 honors3

Honors & Awards

• Academic Achievement Award
• Excellence In Academics Awarded
• The Durham Award

Shantanu Kumar has 3 languages3

Languages

• Arabic
• English
• Hindi

Shantanu Kumar has 3 organizations3

Organizations

• Indian Merchant Chamber
• Rafic Hariri Foundation
• Caritas Internationalis

Shantanu Kumar has 2 certifications2

Certifications

• BSE Certification on IFRS (IFRS)
• BSE Certification on Securities Markets (BCSM)